Abbvie Inc v. Dr. Reddy'S Laboratories, Inc

Court

District Court, D. New Jersey (D.N.J.)
Official Court Website →

Assigned judge

Michael A. Shipp · 5,509 cases in index

Docket number

3:20-cv-09292

Cause

28:1338 Patent Infringement
28 U.S.C. § 1338 — Patent, copyright & trademark jurisdiction

Nature of suit

835 Patent - Abbreviated New Drug Application(ANDA)
Hatch-Waxman patent disputes over a generic-drug (ANDA) application.

Jurisdiction

Federal Question

Jury demand

None

Date filed

07/22/2020

Date terminated

08/28/2020

623 Patent - ANDA cases in this court are indexed here.

Parties

• plaintiff · AbbVie Inc Pharmaceuticals & Biotechnology · 5032 cases
• defendant · Dr. Reddy'S Laboratories, Inc · 76 cases

Part of a Larger Litigation Pattern

This is one of 77 Patent - ANDA cases in our index naming DR. REDDY'S LABORATORIES, INC — a possible mass-tort or coordinated-litigation cluster.

• Bayer Pharma Ag v. Dr. Reddy's Laboratories, Inc
  District Court, D. DelawareFiled 08/19/2025
• Bayer Healthcare LLC v. Dr. Reddy's Laboratories, Inc
  District Court, D. DelawareFiled 07/07/2021
• Intercept Pharmaceuticals, Inc v. Dr. Reddy's Laboratories, Inc
  District Court, D. DelawareFiled 01/13/2021
• Par Pharmaceutical, Inc v. Dr. Reddy'S Laboratories, Inc
  District Court, D. New JerseyFiled 12/07/2020
• Pfizer Inc v. Dr. Reddy's Laboratories, Inc
  District Court, D. DelawareFiled 11/13/2020
• Merck Sharp & Dohme Corp v. Dr. Reddy's Laboratories, Inc
  District Court, D. DelawareFiled 06/24/2020

About Patent - ANDA Lawsuits

ANDA patent cases arise when a generic-drug maker files an Abbreviated New Drug Application and the brand-name patent holder sues for infringement under the Hatch-Waxman Act.

Frequently Asked Questions

What is Abbvie Inc v. Dr. Reddy'S Laboratories, Inc?

Abbvie Inc v. Dr. Reddy'S Laboratories, Inc is a federal patent - anda lawsuit filed on 07/22/2020 in the District Court, D. New Jersey. The case was terminated on 08/28/2020. ANDA patent cases arise when a generic-drug maker files an Abbreviated New Drug Application and the brand-name patent holder sues for infringement under the Hatch-Waxman Act.

What type of case is this?

It is classified as “Patent - ANDA” under the federal nature-of-suit system. ANDA patent cases arise when a generic-drug maker files an Abbreviated New Drug Application and the brand-name patent holder sues for infringement under the Hatch-Waxman Act.

What court is the case in?

The case is in the District Court, D. New Jersey, docket number 3:20-cv-09292.

When was the case filed?

Abbvie Inc v. Dr. Reddy'S Laboratories, Inc was filed on 07/22/2020. It was terminated on 08/28/2020.

What law is the case brought under?

The docket lists the cause as 28 U.S.C. § 1338 — Patent, copyright & trademark jurisdiction.